Depression
Explore how undermethylation, overmethylation, copper imbalance, vitamin D, inflammation, gut health and elevated SAH may contribute to different forms of depression.
Depression articlesDepression, anxiety, ADHD, OCD, insomnia and other mental health conditions are diagnosed primarily by symptoms. Symptoms matter, but they do not always explain why a condition developed, why one medication helped while another failed, or why two people with the same diagnosis respond differently to treatment.
The Walsh Approach adds another question: Which biochemical patterns may be contributing to the symptoms?
Explore how undermethylation, overmethylation, copper imbalance, vitamin D, inflammation, gut health and elevated SAH may contribute to different forms of depression.
Depression articlesLearn how copper overload, pyroluria, methylation status, hormonal changes, stimulant sensitivity and nutrient deficiencies may affect anxiety, panic and nervous-system overactivation.
Anxiety and panic articlesReview possible relationships among attention, dopamine regulation, methylation, zinc, vitamin B6, iron, sleep, gut health and stimulant response.
ADHD articlesUnderstand why obsessive thoughts, perfectionism, compulsive behavior and medication response may warrant evaluation of undermethylation and related biochemical factors.
OCD articlesExplore nutrition, methylation, oxidative stress, immune activation, gut dysfunction, folate receptor antibodies, copper balance and individualized laboratory testing.
Autism articlesConsider how biochemical individuality, medication response, methylation, sleep disruption, inflammation and nutrient status may affect mood instability.
Bipolar disorder articlesLearn why psychosis requires careful stabilization while nutritional, metabolic, inflammatory and biochemical contributors are evaluated as part of a broader treatment strategy.
Schizrenia and psychosis articlesReview how anxiety, copper, methylation, cortisol, hormones, blood sugar, gut discomfort, inflammation and medication effects may interfere with sleep.
Insomnia articlesExplore the relationship among pregnancy, estrogen, copper, ceruloplasmin, zinc, thyroid function, methylation and postpartum mood symptoms.
Postpartum depression articlesUnderstand how copper overload, pyroluria, inflammation, toxic exposure, glucose instability, medication effects and other factors may contribute to severe irritability or behavioral change.
Behavioral health articlesExplore nutrient deficiencies, thyroid function, inflammation, methylation, vascular risk, sleep, infections, toxic burden and metabolic factors affecting cognition.
Memory and cognition articlesLearn how chronic stress may interact with cortisol, sleep, inflammation, nutrient depletion, autonomic function and preexisting biochemical vulnerabilities.
PTSD and stress articlesA Walsh biotype is not a psychiatric diagnosis. It is a biochemical pattern that may appear in more than one condition. A person with depression, anxiety, OCD or ADHD may therefore share certain laboratory findings while still having a different clinical presentation.
No single laboratory test diagnoses depression, anxiety, ADHD or another psychiatric condition. Targeted testing can instead identify biochemical abnormalities that may influence neurotransmitter function, medication response, inflammation, energy production and nutrient treatment.
| Laboratory marker | What it may help evaluate | Related topics |
|---|---|---|
| Serum copper and ceruloplasmin | Copper transport, calculated non-ceruloplasmin-bound copper and copper-related anxiety, irritability or hormonal patterns. | Copper overload, anxiety, panic, postpartum depression and estrogen-related mood symptoms. |
| Plasma zinc | Mineral balance, antioxidant protection and nutrient pathways involved in neurotransmitter regulation. | Copper balance, pyroluria, immune function and behavioral symptoms. |
| Whole-blood histamine | A traditional Walsh marker used alongside symptoms when assessing possible methylation patterns. | Undermethylation, overmethylation, depression, OCD and medication response. |
| SAM, SAH and SAM-to-SAH ratio | Methyl-donor availability and possible inhibition of methyltransferase reactions by elevated SAH. | Methylation, toxic burden, creatine demand, cognition and mood. |
| Homocysteine | One-carbon metabolism and factors affecting the methionine and transsulfuration pathways. | Methylation, B vitamins, cardiovascular risk and cognitive health. |
| 25-hydroxy vitamin D | Vitamin D status relevant to immune regulation, inflammation, bone health and neurological function. | Depression, cognition, immune function and treatment response. |
| Urinary pyrroles | A specialized test used with symptoms and specimen quality when evaluating possible pyroluria. | Zinc and B6 depletion, oxidative stress, anxiety and stress intolerance. |
| CBC, CMP and thyroid testing | Anemia, liver and kidney function, glucose, electrolytes, macrocytosis and thyroid-related contributors. | Fatigue, mood change, cognition, medication safety and general health. |
Review the available mental health and Walsh laboratory testing options before selecting a panel.
Digestion, nutrient absorption, dysbiosis, intestinal inflammation, food reactions and microbial metabolites may influence mood, cognition and immune activity.
Explore gut healthChronic inflammatory and immune signals may affect energy, sleep, motivation, cognition and neurotransmitter metabolism.
Explore inflammationEnvironmental exposure, oxidative stress, impaired clearance and elevated SAH may interfere with biochemical pathways important to neurological function.
Explore toxic burdenThyroid function, cortisol, estrogen, progesterone, testosterone and life-stage hormonal changes can alter mood, sleep, energy and cognition.
Explore hormones and thyroidSelected patients may require evaluation for Lyme disease, mold, mycotoxins, chronic infections or immune-related complications when the clinical history supports it.
Explore infections and exposureProtein intake, nutrient density, food intolerance, blood-sugar instability and inappropriate supplementation may all influence symptoms and biochemical testing.
Explore diet and nutritionNutrient testing and biochemical treatment are not substitutes for immediate psychiatric stabilization when a person has severe depression, suicidal intent, psychosis, mania, dangerous behavior or an inability to care for basic needs. Medication, hospitalization or other urgent intervention may be absolutely necessary.
The longer-term goal is to understand why symptoms developed, identify correctable abnormalities, improve nutrient and metabolic status, and optimize medication selection when medication remains necessary.
Psychiatric medications should not be stopped abruptly. Learn more in the Mental Health Medication Guide .
The questionnaire, laboratory panels and physician consultation provide different levels of assessment. The appropriate starting point depends on the severity and complexity of the symptoms and whether useful recent laboratory results are already available.
Nutrient deficiencies can contribute to neurological and psychiatric symptoms, but they are rarely the only possible explanation. Zinc, vitamin B6, vitamin D, iron, vitamin B12, folate and other nutrients affect biochemical pathways involved in energy, neurotransmitters, immune activity and brain function. Symptoms should be interpreted together with history, medications and appropriate laboratory testing.
The Walsh framework has been applied to symptom patterns associated with depression, anxiety, OCD, ADHD, autism, behavioral disorders, bipolar disorder, schizophrenia and other neuropsychiatric concerns. Walsh biotypes do not replace psychiatric diagnoses; they describe biochemical patterns that may help explain individual differences.
Yes. Depression is a clinical syndrome rather than one uniform biochemical state. One patient may have features associated with undermethylation, while another may have copper imbalance, overmethylation, inflammation, thyroid dysfunction, vitamin D deficiency, medication effects or elevated SAH.
Common testing may include whole-blood histamine, serum copper, ceruloplasmin, plasma zinc, vitamin D, homocysteine, urinary pyrroles, CBC and CMP. SAM and SAH testing may be added when a more direct assessment of methylation is needed. Testing should be individualized.
No. Medication may be essential for severe depression, suicide risk, psychosis, mania or dangerous instability. The immediate priority is stabilization. Biochemical testing and nutrient treatment may then be used to identify correctable factors and potentially improve the overall treatment plan. Any medication reduction should be gradual and supervised by the prescribing clinician.
Gut inflammation, dysbiosis, impaired nutrient absorption, immune activation and selected environmental exposures may affect sleep, energy, cognition and mood. They should be investigated when symptoms, history or initial testing suggest that they are clinically relevant.
Browse the newest Second Opinion Physician articles connecting symptoms, biochemical patterns, laboratory testing, nutrients, gut health, medications and functional treatment.